These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22332932)

  • 1. Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: a population-based, cohort study.
    Stephenson A; Seitz DP; Fischer HD; Gruneir A; Bell CM; Gershon AS; Fu L; Anderson GM; Austin PC; Rochon PA; Gill SS
    Drugs Aging; 2012 Mar; 29(3):213-223. PubMed ID: 22332932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.
    Seitz DP; Gill SS; Gruneir A; Austin PC; Anderson G; Reimer CL; Rochon PA
    Am J Geriatr Psychiatry; 2011 Sep; 19(9):803-13. PubMed ID: 21873836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COPD Exacerbation and Cholinesterase Therapy in Dementia Patients.
    Mahan RJ; Blaszczyk AT
    Consult Pharm; 2016 Apr; 31(4):221-5. PubMed ID: 27056359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.
    Gill SS; Anderson GM; Fischer HD; Bell CM; Li P; Normand SL; Rochon PA
    Arch Intern Med; 2009 May; 169(9):867-73. PubMed ID: 19433698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Opioid-related Adverse Pulmonary Events among Older Adults with Chronic Obstructive Pulmonary Disease.
    Vozoris NT; Pequeno P; Li P; Austin PC; O'Donnell DE; Gershon AS
    Ann Am Thorac Soc; 2020 Aug; 17(8):965-973. PubMed ID: 32396385
    [No Abstract]   [Full Text] [Related]  

  • 6. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaching the population with dementia drugs: what are the challenges?
    Matthews FE; McKeith I; Bond J; Brayne C;
    Int J Geriatr Psychiatry; 2007 Jul; 22(7):627-31. PubMed ID: 17136710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinesterase inhibitors and the risk of pulmonary disorders in hospitalized dementia patients.
    Helou R; Rhalimi M
    J Popul Ther Clin Pharmacol; 2010; 17(3):e379-89. PubMed ID: 21041864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia.
    Inglis F
    Int J Clin Pract Suppl; 2002 Jun; (127):45-63. PubMed ID: 12139367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials.
    Kim DH; Brown RT; Ding EL; Kiel DP; Berry SD
    J Am Geriatr Soc; 2011 Jun; 59(6):1019-31. PubMed ID: 21649634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease.
    Lampela P; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
    J Alzheimers Dis; 2020; 73(3):1243-1251. PubMed ID: 31929157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incident diuretic drug use and adverse respiratory events among older adults with chronic obstructive pulmonary disease.
    Vozoris NT; Wang X; Austin PC; O'Donnell DE; Aaron SD; To TM; Gershon AS
    Br J Clin Pharmacol; 2018 Mar; 84(3):579-589. PubMed ID: 29139564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P
    Drugs Aging; 2019 May; 36(5):435-452. PubMed ID: 30937879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinesterase inhibitors associated with lower rate of mortality in dementia patients with heart failure: a nationwide propensity weighting study.
    Hsieh MJ; Lee CH; Chen DY; Wu CL; Huang YT; Chang SH
    Clin Auton Res; 2023 Dec; 33(6):715-726. PubMed ID: 37935929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada.
    Huang AR; Redpath CJ; van Walraven C
    BMC Neurol; 2015 Apr; 15():66. PubMed ID: 25927641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
    Gershon AS; Campitelli MA; Croxford R; Stanbrook MB; To T; Upshur R; Stephenson AL; Stukel TA
    JAMA; 2014 Sep; 312(11):1114-21. PubMed ID: 25226477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase inhibitors are associated with reduced mortality in patients with Alzheimer's disease and previous myocardial infarction.
    Shahim B; Xu H; Haugaa K; Zetterberg H; Jurga J; Religa D; Eriksdotter M
    Eur Heart J Cardiovasc Pharmacother; 2024 Feb; 10(2):128-136. PubMed ID: 38224338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD.
    Vozoris NT; Wang X; Fischer HD; Bell CM; O'Donnell DE; Austin PC; Stephenson AL; Gill SS; Rochon PA
    Eur Respir J; 2016 Sep; 48(3):683-93. PubMed ID: 27418553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease.
    Le TT; Park S; Choi M; Wijesinha M; Khokhar B; Simoni-Wastila L
    BMJ Open Respir Res; 2020 Mar; 7(1):. PubMed ID: 32213535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.